dr. david reardon on immunotherapy and rindopepimut in the glioblastoma treatment paradigm
Published 8 years ago • 750 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:33
dr. reardon discusses the mechanism of action of rindopepimut for recurrent glioblastoma
-
45:30
immunotherapy for brain cancer, with david reardon
-
1:43
dr. david reardon on treating glioblastoma patients with egfrviii-mutations
-
33:11
brain cancer and immunotherapy with dr. david reardon
-
2:09
dr. reardon on efficacy/safety of immunotherapy combination in glioblastoma
-
0:54
rindopepimut, immunotherapy combination treatments have potential brain cancer
-
1:54
david reardon on caring for patients with glioblastoma
-
0:56
dr. david reardon on targeting brain tumors and monitoring resistances
-
1:55
asco22: glioblastoma research by david reardon, md | dana-farber cancer institute
-
37:38
learn the basics of immunotherapy from david reardon, m.d.
-
59:55
aiming the immune system at brain cancer, with david reardon
-
2:03
dr. reardon on the immunogenicity of glioblastoma
-
2:01
the challenges in using immune checkpoint inhibitors to treat patients with glioblastoma
-
2:17
helping patients with brain cancer: dr. david reardon
-
1:51
the inadequacy of the current standard of care for glioblastoma
-
1:20
dr. reardon on the need for a new standard of care in gbm
-
1:34
dr. reardon on pembrolizumab and bevacizumab for glioblastoma
-
1:36
interim analysis demonstrates reassuring toxicity profile for glioblastoma
-
1:05
dr. reardon on updated data from the phase ii react trial